Stay updated with breaking news from Liquidia Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oral arguments in appeal of ‘793 PTAB decision set for December 4, 2023PDUFA goal date to add PH-ILD indication to YUTREPIA label is January 24, 2024Hired sales force in preparation of potential...
Ben Nelson, the former two-term senator from Nebraska, is joining former Louisiana Sen. John Breaux at Saving America’s Family Enterprises Inc., or SAFE.
On July 24, 2023, the United States Court of Appeals for the Federal Circuit issued a precedential opinion in United Therapeutics Corp. v. Liquidia Technologies, Inc.
Sets PDUFA goal date of January 24, 2024If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD MORRISVILLE, N.C., Sept. 25, 2023 -- Liquidia Corporation announced today...
Asserts ‘793 patent in new litigation filed under Hatch-Waxman Act in response to Liquidia’s amendment to its NDA to add PH-ILD to YUTREPIA™ labelLitigation is tied to same ‘793 patent...